These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 28969385)

  • 21. Megalencephaly, polymicrogyria and ribbon-like band heterotopia: A new cortical malformation.
    Kobayashi Y; Magara S; Okazaki K; Komatsubara T; Saitsu H; Matsumoto N; Kato M; Tohyama J
    Brain Dev; 2016 Nov; 38(10):950-953. PubMed ID: 27381655
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Megalencephaly and hemimegalencephaly: breakthroughs in molecular etiology.
    Mirzaa GM; Poduri A
    Am J Med Genet C Semin Med Genet; 2014 Jun; 166C(2):156-72. PubMed ID: 24888963
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Megalencephaly secondary to a novel germline missense variant p.Asp322Tyr in AKT3 associated with growth hormone deficiency and central hypothyroidism: A case report.
    Renard E; Bonnet C; Di Patrizio M; Schmitt E; Madkaud AC; Chabot C; Kuchenbuch M; Lambert L
    Am J Med Genet A; 2024 Jul; 194(7):e63585. PubMed ID: 38459620
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Germline activating MTOR mutation arising through gonadal mosaicism in two brothers with megalencephaly and neurodevelopmental abnormalities.
    Mroske C; Rasmussen K; Shinde DN; Huether R; Powis Z; Lu HM; Baxter RM; McPherson E; Tang S
    BMC Med Genet; 2015 Nov; 16():102. PubMed ID: 26542245
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sudden death in a case of megalencephaly capillary malformation associated with a de novo mutation in AKT3.
    Harada A; Miya F; Utsunomiya H; Kato M; Yamanaka T; Tsunoda T; Kosaki K; Kanemura Y; Yamasaki M
    Childs Nerv Syst; 2015 Mar; 31(3):465-71. PubMed ID: 25416470
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detailed analysis of phenotypes and genotypes in megalencephaly-capillary malformation-polymicrogyria syndrome caused by somatic mosaicism of PIK3CA mutations.
    Park HJ; Shin CH; Yoo WJ; Cho TJ; Kim MJ; Seong MW; Park SS; Lee JH; Sim NS; Ko JM
    Orphanet J Rare Dis; 2020 Aug; 15(1):205. PubMed ID: 32778138
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel de novo germline mutation Glu40Lys in AKT3 causes megalencephaly with growth hormone deficiency.
    Takagi M; Dobashi K; Nagahara K; Kato M; Nishimura G; Fukuzawa R; Narumi S; Hasegawa T
    Am J Med Genet A; 2017 Apr; 173(4):1071-1076. PubMed ID: 28190287
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Somatic variants in diverse genes leads to a spectrum of focal cortical malformations.
    Lai D; Gade M; Yang E; Koh HY; Lu J; Walley NM; Buckley AF; Sands TT; Akman CI; Mikati MA; McKhann GM; Goldman JE; Canoll P; Alexander AL; Park KL; Von Allmen GK; Rodziyevska O; Bhattacharjee MB; Lidov HGW; Vogel H; Grant GA; Porter BE; Poduri AH; Crino PB; Heinzen EL
    Brain; 2022 Aug; 145(8):2704-2720. PubMed ID: 35441233
    [TBL] [Abstract][Full Text] [Related]  

  • 29. De novo CCND2 mutations leading to stabilization of cyclin D2 cause megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome.
    Mirzaa G; Parry DA; Fry AE; Giamanco KA; Schwartzentruber J; Vanstone M; Logan CV; Roberts N; Johnson CA; Singh S; Kholmanskikh SS; Adams C; Hodge RD; Hevner RF; Bonthron DT; Braun KPJ; Faivre L; Rivière JB; St-Onge J; Gripp KW; Mancini GM; Pang K; Sweeney E; van Esch H; Verbeek N; Wieczorek D; Steinraths M; Majewski J; ; Boycot KM; Pilz DT; Ross ME; Dobyns WB; Sheridan EG
    Nat Genet; 2014 May; 46(5):510-515. PubMed ID: 24705253
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypoinsulinaemic, hypoketotic hypoglycaemia due to mosaic genetic activation of PI3-kinase.
    Leiter SM; Parker VER; Welters A; Knox R; Rocha N; Clark G; Payne F; Lotta L; Harris J; Guerrero-Fernández J; González-Casado I; García-Miñaur S; Gordo G; Wareham N; Martínez-Glez V; Allison M; O'Rahilly S; Barroso I; Meissner T; Davies S; Hussain K; Temple K; Barreda-Bonis AC; Kummer S; Semple RK
    Eur J Endocrinol; 2017 Aug; 177(2):175-186. PubMed ID: 28566443
    [TBL] [Abstract][Full Text] [Related]  

  • 31. mTOR pathway: Insights into an established pathway for brain mosaicism in epilepsy.
    Gerasimenko A; Baldassari S; Baulac S
    Neurobiol Dis; 2023 Jun; 182():106144. PubMed ID: 37149062
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular characterization of 13 patients with PIK3CA-related overgrowth spectrum using a targeted deep sequencing approach.
    de Kock L; Cuillerier A; Gillespie M; Couse M; Hartley T; Mears W; Bernier FP; Chudley AE; Frosk P; Nikkel SM; Innes AM; Lauzon J; Thomas M; Guerin A; Armour CM; Weksberg R; Scott JN; Watkins D; Harvey S; Cytrynbaum C; ; Kernohan KD; Boycott KM
    Am J Med Genet A; 2024 Mar; 194(3):e63466. PubMed ID: 37949664
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical pitfalls in the diagnosis of segmental overgrowth syndromes: a child with the c.2740G > A mutation in PIK3CA gene.
    Maguolo A; Antoniazzi F; Spano A; Fiorini E; Gaudino R; Mauro M; Cantalupo G; Biban P; Maitz S; Cavarzere P
    Ital J Pediatr; 2018 Sep; 44(1):110. PubMed ID: 30231930
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Somatic mosaicism of the PI3K-AKT-MTOR pathway is associated with hemimegalencephaly in fetal brains.
    Itoh K; Pooh R; Shimokawa O; Fushiki S
    Neuropathology; 2023 Apr; 43(2):190-196. PubMed ID: 36325654
    [TBL] [Abstract][Full Text] [Related]  

  • 35. De novo somatic mutations in components of the PI3K-AKT3-mTOR pathway cause hemimegalencephaly.
    Lee JH; Huynh M; Silhavy JL; Kim S; Dixon-Salazar T; Heiberg A; Scott E; Bafna V; Hill KJ; Collazo A; Funari V; Russ C; Gabriel SB; Mathern GW; Gleeson JG
    Nat Genet; 2012 Jun; 44(8):941-5. PubMed ID: 22729223
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epilepsy with faint capillary malformation or reticulated telangiectasia associated with mosaic AKT3 pathogenic variants.
    De Bortoli M; Ivars M; Revencu N; Nassogne MC; Lavarino C; Paco S; Lammens M; Renders A; Dumitriu D; Helaers R; Boon LM; Baselga E; Vikkula M
    Am J Med Genet A; 2024 Jun; 194(6):e63551. PubMed ID: 38321651
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PIK3R2/Pik3r2 Activating Mutations Result in Brain Overgrowth and EEG Changes.
    Shi X; Lim Y; Myers AK; Stallings BL; Mccoy A; Zeiger J; Scheck J; Cho G; Marsh ED; Mirzaa GM; Tao T; Golden JA
    Ann Neurol; 2020 Dec; 88(6):1077-1094. PubMed ID: 32856318
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proximal variants in CCND2 associated with microcephaly, short stature, and developmental delay: A case series and review of inverse brain growth phenotypes.
    Pirozzi F; Lee B; Horsley N; Burkardt DD; Dobyns WB; Graham JM; Dentici ML; Cesario C; Schallner J; Porrmann J; Di Donato N; Sanchez-Lara PA; Mirzaa GM
    Am J Med Genet A; 2021 Sep; 185(9):2719-2738. PubMed ID: 34087052
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Megalencephaly syndromes: exome pipeline strategies for detecting low-level mosaic mutations.
    Tapper WJ; Foulds N; Cross NC; Aranaz P; Score J; Hidalgo-Curtis C; Robinson DO; Gibson J; Ennis S; Temple IK; Collins A
    PLoS One; 2014; 9(1):e86940. PubMed ID: 24497998
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mouse models of human PIK3CA-related brain overgrowth have acutely treatable epilepsy.
    Roy A; Skibo J; Kalume F; Ni J; Rankin S; Lu Y; Dobyns WB; Mills GB; Zhao JJ; Baker SJ; Millen KJ
    Elife; 2015 Dec; 4():. PubMed ID: 26633882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.